JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB322352

Anti-CARD9 抗体 [EPR28960-91]

Anti-CARD9 antibody [EPR28960-91]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal CARD9 antibody. Suitable for Flow Cyt (Intra), WB and reacts with Human, Mouse samples.

別名を表示する

Caspase recruitment domain-containing protein 9, hCARD9, CARD9

4 Images
Flow Cytometry (Intracellular) - Anti-CARD9 antibody [EPR28960-91] (AB322352)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-CARD9 antibody [EPR28960-91] (AB322352)

Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized A549 (human lung carcinoma epithelial cell, Left) / THP-1 (human monocytic leukemia monocyte, Right) cells labelling CARD9 with ab322352 at 1/5000 (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue).

Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081 at 1/5000 was used as the secondary antibody.

Low expression : A549.

Flow Cytometry (Intracellular) - Anti-CARD9 antibody [EPR28960-91] (AB322352)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-CARD9 antibody [EPR28960-91] (AB322352)

Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized MEF (mouse embryo fibroblast, Left)/ RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage, Right) cells labelling CARD9 with ab322352 at 1/5000 (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue).

Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081 at 1/5000 was used as the secondary antibody.

Negative Control : MEF.

Western blot - Anti-CARD9 antibody [EPR28960-91] (AB322352)
  • WB

Supplier Data

Western blot - Anti-CARD9 antibody [EPR28960-91] (AB322352)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Low expression : A549 (PMID : 32164050 ), 293T (PMID : 33558980).

The expression profile/ molecular weight observed is consistent with what has been described in the literature(PMID : 32164050), This antibody can recognize 3 isoforms of CARD9 and isoforms have different molecular weight.

The identity of the higher MW band at 150 kDa (in lane 1) is unknown.

The identity of the lower MW band at 25 kDa (in lane 5) is unknown.

This blot of lane 1 and lane 5 was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

All lanes:

Western blot - Anti-CARD9 antibody [EPR28960-91] (ab322352) at 1/1000 dilution

Lane 1:

K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg

Lane 2:

THP-1 (human monocytic leukemia monocyte) whole cell lysate at 20 µg

Lane 3:

A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 4:

293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg

Lane 5:

Human bone marrow tissue lysate at 40 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 43-62 kDa,36 kDa

false

Exposure time: 180s

Western blot - Anti-CARD9 antibody [EPR28960-91] (AB322352)
  • WB

Supplier Data

Western blot - Anti-CARD9 antibody [EPR28960-91] (AB322352)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Negative control : MEF.

Low expression : skeletal muscle (PMID : 11053425).

The expression profile/ molecular weight observed is consistent with what has been described in the literature(PMID : 32164050), This antibody can recognize 3 isoforms of CARD9 and isoforms have different molecular weight.

The identity of the lower MW band at about 30 kDa (in lane 1) is unknown.

The identity of the higher MW bands at about 100 kDa and the lower MW bands at about 40 kDa (in lane 4) are unknown.

This blot of lanes 3-4 was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

All lanes:

Western blot - Anti-CARD9 antibody [EPR28960-91] (ab322352) at 1/1000 dilution

Lane 1:

RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 40 µg

Lane 2:

MEF (mouse embryo fibroblast) whole cell lysate at 40 µg

Lane 3:

Mouse spleen tissue lysate at 40 µg

Lane 4:

Mouse skeletal muscle lysate at 40 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 43-62 kDa,36 kDa

false

Exposure time: 136s

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-CARD9 antibody [EPR28960-91] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR28960-91

アイソタイプ

IgG

キャリアフリー

No

交差種

Human, Mouse

アプリケーション

WB, Flow Cyt (Intra)

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/5000", "FlowCytIntra-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/5000", "FlowCytIntra-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Conditional Ambient
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Adapter protein that plays a key role in innate immune response against fungi by forming signaling complexes downstream of C-type lectin receptors (PubMed : 26961233, PubMed : 33558980). CARD9-mediated signals are essential for antifungal immunity against a subset of fungi from the phylum Ascomycota (PubMed : 24231284, PubMed : 25057046, PubMed : 25702837, PubMed : 26521038, PubMed : 26679537, PubMed : 26961233, PubMed : 27777981, PubMed : 29080677, PubMed : 33558980). Transduces signals in myeloid cells downstream of C-type lectin receptors CLEC7A (dectin-1), CLEC6A (dectin-2) and CLEC4E (Mincle), which detect pathogen-associated molecular pattern metabolites (PAMPs), such as fungal carbohydrates, and trigger CARD9 activation (By similarity). Upon activation, CARD9 homooligomerizes to form a nucleating helical template that recruits BCL10 via CARD-CARD interaction, thereby promoting polymerization of BCL10 and subsequent recruitment of MALT1 : this leads to activation of NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines (PubMed : 11053425, PubMed : 26488816, PubMed : 26961233, PubMed : 31296852, PubMed : 33558980). CARD9 signaling in antigen-presenting cells links innate sensing of fungi to the activation of adaptive immunity and provides a cytokine milieu that induces the development and subsequent of interleukin 17-producing T helper (Th17) cells (PubMed : 24231284). Also involved in activation of myeloid cells via classical ITAM-associated receptors and TLR : required for TLR-mediated activation of MAPK, while it is not required for TLR-induced activation of NF-kappa-B (By similarity). CARD9 can also be engaged independently of BCL10 : forms a complex with RASGRF1 downstream of C-type lectin receptors, which recruits and activates HRAS, leading to ERK activation and the production of cytokines (By similarity). Acts as an important regulator of the intestinal commensal fungi (mycobiota) component of the gut microbiota (PubMed : 33548172). Plays an essential role in antifungal immunity against dissemination of gut fungi : acts by promoting induction of antifungal IgG antibodies response in CX3CR1(+) macrophages to confer protection against disseminated C.albicans or C.auris infection (PubMed : 33548172). Also mediates immunity against other pathogens, such as certain bacteria, viruses and parasites; CARD9 signaling is however redundant with other innate immune responses (By similarity). In response to L.monocytogenes infection, required for the production of inflammatory cytokines activated by intracellular peptidoglycan : acts by connecting NOD2 recognition of peptidoglycan to downstream activation of MAP kinases (MAPK) without activating NF-kappa-B (By similarity).
See full target information CARD9

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com